Estrogen Therapy in Non-severe COVID-19 Patients

• Status: Recruiting
• Trial end date: 2022-12-01

Summary

The primary objective of this study is to evaluate the effect of additional estradiol estrogen therapy on clinical response and mortality in non-severe COVID-19 patients

• Phase: N/A

Details

• Lead Sponsor: CMN "20 de Noviembre"
• Treatments: Estradiol; Estrogens; Ethinyl Estradiol